Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonella Castagna

Showing results (371-380 of 467) with videos related to

Pageof 47
Sort By:
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2021
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort studyCaterina Conte, Antonio Esposito, Rebecca De Lorenzo, et al.
AIDS (London, England)|May 4, 2021
Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1Peter Ackerman, Melanie Thompson, Jean-Michel Molina, et al.
Andrology|August 19, 2021
Testosterone in males with COVID-19: A 7-month cohort studyAndrea Salonia, Marina Pontillo, Paolo Capogrosso, et al.
Plos Medicine|March 27, 2012
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE, Jim Young, Mina Psichogiou, et al.
The Lancet Regional Health. Europe|July 22, 2024
All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort studyChristian Kraef, Erich Tusch, Sabine Singh, et al.
Journal of the International AIDS Society|November 15, 2014
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trialMassimiliano Fabbiani, Simona Di Giambenedetto, Eugenia Quiros-Roldan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
Changing clinical and laboratory characteristics of Progressive Multifocal Leukoencephalopathy: a retrospective national cohort studyIlaria Mainardi, Simonetta Gerevini, Andrea Tarantino, et al.
Therapeutic Advances in Infectious Disease|October 1, 2024
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipientsFrancesca Farina, Andrea Acerbis, Chiara Oltolini, et al.
Open Forum Infectious Diseases|June 26, 2024
Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIVAshley O Roen, Lars Peters, Gilles Wandeler, et al.
The Journal of Antimicrobial Chemotherapy|January 18, 2017
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quiros Roldan, et al.
Pageof 47

Showing results (371-380 of 467) with videos related to

Sort By:
Pageof 47
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|June 1, 2021
Epicardial adipose tissue characteristics, obesity and clinical outcomes in COVID-19: A post-hoc analysis of a prospective cohort studyCaterina Conte, Antonio Esposito, Rebecca De Lorenzo, et al.
AIDS (London, England)|May 4, 2021
Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1Peter Ackerman, Melanie Thompson, Jean-Michel Molina, et al.
Andrology|August 19, 2021
Testosterone in males with COVID-19: A 7-month cohort studyAndrea Salonia, Marina Pontillo, Paolo Capogrosso, et al.
Plos Medicine|March 27, 2012
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE, Jim Young, Mina Psichogiou, et al.
The Lancet Regional Health. Europe|July 22, 2024
All-cause and AIDS-related mortality among people with HIV across Europe from 2001 to 2020: impact of antiretroviral therapy, tuberculosis and regional differences in a multicentre cohort studyChristian Kraef, Erich Tusch, Sabine Singh, et al.
Journal of the International AIDS Society|November 15, 2014
Simplification to atazanavir/ritonavir+lamivudine in virologically suppressed HIV-infected patients: 24-weeks interim analysis from ATLAS-M trialMassimiliano Fabbiani, Simona Di Giambenedetto, Eugenia Quiros-Roldan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 9, 2025
Changing clinical and laboratory characteristics of Progressive Multifocal Leukoencephalopathy: a retrospective national cohort studyIlaria Mainardi, Simonetta Gerevini, Andrea Tarantino, et al.
Therapeutic Advances in Infectious Disease|October 1, 2024
Coadministration of isavuconazole and sirolimus in allogeneic hematopoietic stem cell transplant recipientsFrancesca Farina, Andrea Acerbis, Chiara Oltolini, et al.
Open Forum Infectious Diseases|June 26, 2024
Chronic Liver Enzyme Elevation and Use of Contemporary ARVs Among People With HIVAshley O Roen, Lars Peters, Gilles Wandeler, et al.
The Journal of Antimicrobial Chemotherapy|January 18, 2017
Treatment simplification to atazanavir/ritonavir + lamivudine versus maintenance of atazanavir/ritonavir + two NRTIs in virologically suppressed HIV-1-infected patients: 48 week results from a randomized trial (ATLAS-M)Simona Di Giambenedetto, Massimiliano Fabbiani, Eugenia Quiros Roldan, et al.
Pageof 47